EUVIMEDEUVIMED entdecken
Open Access

Substance Use Disorder Outcomes and Treatment by Autism Status in Medicaid Enrollees With Substance Use Disorder

Victor Lushin iD, Lindsay Shea, Jonas Ventimiglia, Ming Xie, Steven Marcus

Autism Research · 2026-08 · 19 (8)

DOI: 10.1002/aur.70291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Autism Research, online erschienen am 16.07.2026. Verfasst von Victor Lushin und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Substance-Related Disorders, Medicaid, Autistic Disorder. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, Intramural NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of substance use disorders (SUD) among autistic people is substantial and growing. This unaddressed public health challenge is particularly important given the lack of knowledge about SUD service needs among people on the spectrum. This paper presents the first national‐level study of SUD‐related clinical outcomes and service use among US‐based autistic Medicaid enrollees with SUD ( N = 50,487) compared to matched neurotypical enrollees with SUD ( N = 151,461). The analyses reveal that overdose, hospitalizations, and some polysubstance use risks are elevated among autistic people with SUD compared to neurotypical SUD patients. Analyses also suggest that autistic people with SUD use fewer SUD services compared to their neurotypical counterparts. Results highlight the need for integrative, evidence‐based autism‐tailored SUD service solutions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance-Related DisordersMedicaidAutistic DisorderHumansUnited StatesFemaleMaleAdultHospitalizationAdolescentChildYoung AdultTreatment OutcomePrevalence

Stichwörter der Autor:innen

autismhospitalizationoverdosepolysubstance usesubstance use disorders

Autor:innen und Institutionen

  • National Institutes of Health, Bethesda, Maryland, USA.
  • Drexel Autism Institute, Drexel University, Philadelphia, Pennsylvania, USA.
  • Center for Mental Health, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvaniav, USA.

ORCID-Profile: Victor Lushin

Förderung

  • NIDA NIH HHS
  • Intramural NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Lushin, V., Shea, L., Ventimiglia, J., Xie, M., & Marcus, S. (2026). Substance Use Disorder Outcomes and Treatment by Autism Status in Medicaid Enrollees With Substance Use Disorder. Autism Research, 19(8). https://doi.org/10.1002/aur.70291

Vancouver

Lushin V, Shea L, Ventimiglia J, Xie M, Marcus S. Substance Use Disorder Outcomes and Treatment by Autism Status in Medicaid Enrollees With Substance Use Disorder. Autism Research. 2026;19(8). doi:10.1002/aur.70291

BibTeX
@article{Lushin2026,
  author = {Lushin, Victor and Shea, Lindsay and Ventimiglia, Jonas and Xie, Ming and Marcus, Steven},
  title = {Substance Use Disorder Outcomes and Treatment by Autism Status in Medicaid Enrollees With Substance Use Disorder},
  journal = {Autism Research},
  year = {2026},
  volume = {19},
  number = {8},
  doi = {10.1002/aur.70291}
}
Kostenlos starten →